Salicylate Overdose

Quick Reference

Critical Alerts

• Salicylate poisoning can be rapidly fatal - aggressive treatment is essential
• Mixed acid-base disorder: Respiratory alkalosis + metabolic acidosis is pathognomonic
• Never intubate without addressing acidosis - rapid cardiovascular collapse can occur
• Hemodialysis is definitive treatment for severe toxicity - early consultation critical
• Serial salicylate levels are essential - delayed absorption with enteric-coated formulations
• CNS glucose depletion occurs despite normal serum glucose - always give dextrose

Key Diagnostics

• Serum salicylate level (therapeutic: 10-30 mg/dL; toxic: greater than 40 mg/dL)
• Arterial blood gas (mixed respiratory alkalosis + metabolic acidosis)
• Basic metabolic panel (anion gap acidosis, hypokalemia common)
• Serum lactate (elevated in severe toxicity, poor prognostic sign)
• Urine pH (target greater than 7.5 with alkalinization therapy)
• Serum glucose (may be normal, but CNS glucose depleted)

Emergency Treatments

• Activated charcoal: 1 g/kg (max 50g) if within 2 hours, or later for enteric-coated
• Urinary alkalinization: Sodium bicarbonate 150 mEq in 1L D5W at 150-200 mL/hr
• Dextrose supplementation: Essential despite normal serum glucose (CNS depletion)
• Potassium replacement: Critical for successful alkalinization (maintain K+ 4.0 mEq/L)
• Hemodialysis: Level 90-100 mg/dL, altered mental status, pH less than 7.2, refractory acidosis
• Avoid intubation if possible - if essential: pre-treat with bicarbonate, hyperventilate, arrange emergent dialysis

---

Overview

Salicylate toxicity is a potentially life-threatening poisoning resulting from acute ingestion or chronic accumulation of aspirin (acetylsalicylic acid) or related salicylate compounds. Despite declining use of aspirin as an analgesic, salicylate poisoning remains an important cause of morbidity and mortality, particularly in intentional overdoses and in elderly patients on chronic therapy. [1,2]

The condition is characterized by complex metabolic derangements, most notably a mixed respiratory alkalosis and high anion gap metabolic acidosis. The pathophysiology involves direct CNS stimulation, uncoupling of mitochondrial oxidative phosphorylation, and pH-dependent tissue distribution that makes acidemia particularly dangerous. Understanding these mechanisms is essential for appropriate management and avoiding potentially fatal interventions. [3,4]

Salicylate toxicity requires aggressive, multi-modal treatment including gastrointestinal decontamination, urinary alkalinization, electrolyte repletion, and hemodialysis in severe cases. Early recognition and treatment significantly improve outcomes, while delays or inappropriate management (particularly premature intubation without addressing acidosis) can be catastrophic. [5,6]

---

Epidemiology

Incidence and Prevalence

Salicylate exposures account for approximately 3-5% of all poisoning cases reported to poison control centers in the United States. While the absolute number has declined with reduced over-the-counter aspirin use, salicylate poisoning remains clinically significant due to high morbidity and mortality in severe cases. [7]

Key Statistics:

• Annual incidence: ~20,000-30,000 exposures reported to US poison centers
• Mortality rate: 1-2% in acute overdose; up to 25% in chronic toxicity
• Age distribution: Bimodal (intentional overdose in young adults; chronic toxicity in elderly)
• Gender: Females slightly more common in intentional overdoses (consistent with general poisoning patterns)

Risk Factors

Acute Overdose:

• Intentional self-harm (most common in adults)
• Therapeutic error (confusion about doses, combination products)
• Pediatric exploratory ingestion (though less common with child-resistant packaging)
• Easy availability of aspirin-containing products

Chronic Toxicity:

• Advanced age (greater than 65 years) - reduced renal clearance, polypharmacy
• Chronic pain conditions requiring regular aspirin use
• Renal impairment (any degree) - reduced salicylate elimination
• Volume depletion - concentrates serum levels
• Cognitive impairment - medication errors
• Concurrent NSAID use - additive toxicity
• Acidemia from other causes - enhances tissue distribution

Mortality Determinants

Factors associated with increased mortality include: [8]

• Chronic toxicity (worse than acute at same levels)
• Advanced age
• Delayed presentation (greater than 24 hours from ingestion)
• Severe acidemia (pH less than 7.1)
• CNS depression or seizures
• Pulmonary edema or ARDS
• Cardiovascular collapse
• Renal failure
• Peak salicylate level greater than 100 mg/dL

---

Definition and Classification

Sources of Salicylates

Critical Warning: Oil of wintergreen is extremely concentrated. A single teaspoon (5 mL) contains approximately 7 grams of salicylate, equivalent to 21 adult aspirin tablets. Pediatric ingestions are frequently fatal. [9]

Toxicity Thresholds

Understanding dose-toxicity relationships helps guide initial risk stratification, although clinical presentation and serum levels are more important than reported dose alone. [10]

Important Caveats:

• Reported dose is often unreliable (intentional ingestions, confused patients, unknown pills)
• Enteric-coated or sustained-release formulations have significantly delayed absorption
• Chronic toxicity produces severe symptoms at much lower doses (50-60 mg/dL can be life-threatening)
• Co-ingestants may alter presentation and complicate management
• Individual susceptibility varies widely (elderly, renal impairment, volume depletion, acidemia)
• Bezoar formation can occur with massive ingestions, causing prolonged absorption

Classification by Pattern

Chronic vs Acute Toxicity - Critical Differences:

Chronic salicylate toxicity is particularly dangerous and often underrecognized:

• Presents with nonspecific symptoms (confusion, falls, "just not right")
• Frequently misdiagnosed as sepsis, delirium, dementia, or decompensated heart failure
• Severe toxicity occurs at lower serum levels (50-60 mg/dL can be critical)
• Greater tissue distribution has already occurred
• Mortality rate 2-3 times higher than acute toxicity
• Done nomogram is NOT applicable
• Higher index of suspicion required in elderly with altered mental status [11]

---

Pathophysiology

Salicylate toxicity produces a complex array of metabolic disturbances through multiple mechanisms. Understanding these pathways is essential for recognizing clinical presentations and guiding treatment decisions. [1,2]

Direct Respiratory Center Stimulation

Salicylates directly stimulate the medullary respiratory center, independent of pH or CO2 levels. This central effect produces:

Primary Respiratory Alkalosis:

• Hyperventilation with increased minute ventilation
• Decreased PaCO2 (often 10-20 mmHg in moderate-severe toxicity)
• Initial elevation in pH (may be greater than 7.5 early)
• Compensatory renal bicarbonate wasting (takes hours)

Clinical Significance:

• This respiratory alkalosis is initially protective
• Maintains extracellular pH, limiting salicylate tissue penetration
• Loss of compensation (respiratory fatigue, intubation) → rapid deterioration
• Hyperventilation is often the first and most consistent clinical sign
• Respiratory rate often 30-40 breaths/min in significant toxicity [3,12]

Uncoupling of Oxidative Phosphorylation

Salicylates act as mitochondrial toxins by uncoupling oxidative phosphorylation, the fundamental mechanism of cellular energy production:

Mechanism:

• Salicylates shuttle protons across inner mitochondrial membrane
• Disrupts electrochemical gradient required for ATP synthase
• Energy dissipated as heat rather than captured as ATP
• Oxygen consumption increases but ATP production falls
• Cells become energy-depleted despite adequate oxygen delivery

Downstream Metabolic Consequences:

1. Hyperthermia

   • Direct heat generation from inefficient metabolism
   • Can exceed 40°C (104°F) in severe toxicity
   • Contributes significantly to morbidity
   • Refractory to antipyretics (mechanism bypasses normal thermoregulation)

2. Increased Metabolic Rate

   • Compensatory attempt to maintain ATP production
   • Further increases oxygen consumption and heat generation
   • Depletes energy substrates (glucose, glycogen)

3. Lactic Acidosis

   • Shift to anaerobic metabolism
   • Lactate accumulates from impaired mitochondrial metabolism
   • Contributes to anion gap acidosis
   • Elevated lactate is poor prognostic sign

4. Ketoacidosis

   • Lipid metabolism for alternative energy source
   • β-hydroxybutyrate and acetoacetate accumulation
   • Contributes to anion gap acidosis
   • May cause positive ketones on urinalysis

The degree of uncoupling correlates directly with toxicity severity and contributes significantly to morbidity and mortality. This mechanism explains why salicylate toxicity can be refractory to standard supportive measures. [4,5]

Metabolic Derangements

The combination of respiratory stimulation and mitochondrial toxicity produces a characteristic pattern of metabolic disturbances:

The CNS Glucose Paradox

One of the most critical and counterintuitive aspects of salicylate toxicity is the CNS-plasma glucose discordance. This phenomenon has major treatment implications. [6,7]

Mechanism:

• Salicylates competitively inhibit glucose transport across the blood-brain barrier
• Increased CNS metabolic demand from mitochondrial toxicity
• Impaired CNS gluconeogenesis
• CNS glucose falls despite normal or even elevated serum levels
• Neuroglycopenic symptoms with apparent "normoglycemia"

Clinical Manifestations:

• Altered mental status may reflect CNS glucose depletion, not just salicylate itself
• Agitation, confusion, seizures can be neuroglycopenic
• Serum glucose is NOT a reliable indicator of CNS glucose status
• Hypoglycemia, if present, indicates severe toxicity and very poor prognosis

Critical Management Principle: All patients with significant salicylate toxicity must receive IV dextrose-containing fluids (D5W or higher), regardless of normal or elevated serum glucose levels. This is a fundamental principle of salicylate poisoning management and must never be omitted. [6]

Tissue Distribution and the pH Trap

Salicylate distribution between tissues and plasma is pH-dependent, with profound clinical and therapeutic implications. This is one of the most important concepts in salicylate toxicity. [8,9]

Chemistry Principles:

• pKa of salicylic acid = 3.0
• At physiologic pH (7.4): ~99.96% exists as ionized salicylate ion
• Ionized form (negatively charged) cannot cross lipid membranes
• Only unionized salicylic acid crosses cell membranes and blood-brain barrier

pH-Dependent Distribution:

Critical Clinical Implications:

1. Why Acidosis is Catastrophic

   • Even small pH decreases dramatically increase tissue salicylate
   • pH 7.4 → 7.2 can DOUBLE intracellular salicylate concentrations
   • Increased CNS salicylate causes seizures, coma, death
   • Acidosis begets more acidosis (positive feedback loop)

2. Why Alkalinization Works

   • Higher pH → greater ionization → "trapping" in plasma and urine
   • Prevents tissue entry and enhances renal elimination
   • Even modest alkalinization (pH 7.45-7.55) has major effect
   • Urinary alkalinization also traps ionized salicylate in urine, preventing reabsorption

3. Why Intubation is Dangerous

   • Mechanical ventilation typically reduces minute ventilation
   • PaCO2 rises (respiratory acidosis)
   • pH drops acutely
   • Massive CNS salicylate influx within minutes
   • Cardiovascular collapse and death can occur rapidly
   • Called "crashing after intubation"

• well-described phenomenon [13]

4. Why Respiratory Alkalosis is Protective
   • Compensatory hyperventilation maintains pH
   • Limits tissue distribution despite high plasma levels
   • Respiratory fatigue is an ominous sign (impending acidosis)

The pH Trap Positive Feedback Loop:

• Acidosis → ↑ tissue salicylate → ↑ mitochondrial toxicity → ↑ lactate → ↑ acidosis
• This loop can rapidly become irreversible without intervention
• Breaking the cycle requires aggressive alkalinization ± hemodialysis

Renal Effects

Salicylates affect kidney function through multiple direct and indirect mechanisms: [14]

Direct Nephrotoxicity:

• Acute tubular necrosis (high concentrations)
• Acute interstitial nephritis (particularly chronic use)
• Papillary necrosis (rare, usually chronic toxicity)
• Impaired concentrating ability

Indirect Effects:

• Dehydration → prerenal azotemia (most common)
• Hypotension/shock → acute kidney injury
• Rhabdomyolysis → myoglobin-induced AKI (severe cases with seizures, hyperthermia)
• Increased renal oxygen demand with decreased ATP availability

Altered Renal Handling of Uric Acid (dose-dependent):

• Low doses (less than 2g/day): Decreased uric acid excretion → hyperuricemia
• High doses (greater than 3g/day): Increased uric acid excretion → hypouricemia
• Paradoxical effect related to competition at different transporters

Impact on Management:

• AKI reduces salicylate clearance, worsening toxicity
• Renal failure is indication for hemodialysis (clearance + toxin removal)
• Urine alkalinization may be difficult with AKI
• Monitor renal function closely

Hematologic Effects

Platelet Dysfunction:

• Irreversible acetylation of cyclooxygenase-1 (COX-1) in platelets
• Impaired thromboxane A2 synthesis
• Prolonged bleeding time (effect lasts 7-10 days - lifespan of platelets)
• Increased risk of bleeding (especially GI mucosa already damaged)

Coagulopathy (high doses/chronic use):

• Vitamin K-dependent clotting factor inhibition (II, VII, IX, X)
• Direct hepatotoxicity affecting synthesis factors
• Hypoprothombinemia → elevated PT/INR
• May require FFP or vitamin K if bleeding

Hemolysis:

• Rare complication
• More common in G6PD deficiency
• Oxidative stress on red blood cells
• Can contribute to acidosis and acute kidney injury

Gastrointestinal Effects

Direct Mucosal Injury:

• Uncouples oxidative phosphorylation in gastric mucosa
• Decreases mucosal prostaglandin production
• Impairs mucosal barrier function and bicarbonate secretion
• Back-diffusion of gastric acid into mucosa
• Erosions, ulcerations, and frank bleeding
• Can occur even with enteric-coated formulations

Systemic Effects:

• Stimulation of chemoreceptor trigger zone (CTZ) → nausea and vomiting
• Increased gastric acid secretion
• Delayed gastric emptying (in toxicity)
• May form bezoar with massive ingestions

Pulmonary Effects

Non-cardiogenic Pulmonary Edema:

• Increased pulmonary capillary permeability
• Mechanism poorly understood (direct endothelial toxicity)
• Fluid accumulation despite normal cardiac function
• More common in chronic toxicity and elderly
• Ominous sign requiring ICU and often hemodialysis [15]

ARDS:

• Acute respiratory distress syndrome in severe cases
• Inflammatory cascade triggered by severe toxicity
• Requires mechanical ventilation (with extreme caution)

---

Clinical Presentation

The clinical presentation of salicylate toxicity varies depending on the dose, timing (acute vs chronic), and individual patient factors. Recognition requires high clinical suspicion, particularly for chronic toxicity in elderly patients. [16]

Temporal Progression (Acute Ingestion)

Note: Timing is variable and depends on formulation (immediate vs enteric-coated), dose, and co-ingestants. Some patients progress rapidly through stages.

Symptoms by Organ System

Gastrointestinal (Very Common, Early)

• Nausea and vomiting (60-80% of cases)
• Epigastric pain or burning
• Abdominal pain
• Hematemesis or melena (GI bleeding from direct mucosal injury)
• Symptoms may be mild or absent in chronic toxicity

Neurological (Common, Progression Indicates Severity)

• Tinnitus (classic early sign; "ringing in ears")
  • Occurs at therapeutic levels (greater than 20 mg/dL)
  • Nearly universal in acute toxicity
  • May be absent in chronic toxicity or if patient has hearing loss
• Decreased hearing acuity
• Agitation, restlessness (early)
• Confusion, disorientation (moderate)
• Lethargy progressing to obtundation (severe)
• Seizures (late, ominous sign indicating severe CNS toxicity)
• Coma (severe; often follows intubation or indicates irreversible toxicity)

Respiratory (Hallmark Finding)

• Hyperventilation (most consistent finding)
  • Respiratory rate often 30-40 breaths/min
  • Deep, labored breathing (hyperpnea)
  • May be subtle or attributed to anxiety in early stages
• Dyspnea (feeling of breathlessness despite hyperventilation)
• Pulmonary edema (late, severe)
  • Rales on auscultation
  • Hypoxia
  • Pink, frothy sputum (severe)
• ARDS (severe, requires mechanical ventilation)

Metabolic/Endocrine

• Hyperthermia (from uncoupling)
  • Can exceed 40°C (104°F)
  • Refractory to antipyretics
  • More common in severe toxicity
• Diaphoresis (profuse sweating)
• Dehydration (vomiting, fever, insensible losses)

Cardiovascular

• Tachycardia (nearly universal)
• Hypotension (late, ominous)
  • Initially may have normal or elevated BP
  • Hypotension indicates severe toxicity or volume depletion
• Arrhythmias (rare; usually due to electrolyte disturbances or hypoxia)
• Cardiovascular collapse (terminal event)

Other

• Tinnitus and hearing disturbances
• Visual disturbances, blurred vision
• Vertigo, dizziness

Physical Examination Findings

Key Examination Findings by Severity:

Mild Toxicity:

• Tinnitus
• Mild nausea
• Tachypnea (subtle)
• Otherwise normal examination

Moderate Toxicity:

• Marked hyperventilation (obvious, patient distressed)
• Vomiting
• Fever
• Agitation or confusion
• Diaphoresis

Severe Toxicity:

• Altered mental status (lethargy, obtundation)
• Hyperpnea (Kussmaul-like breathing)
• High fever
• Hypotension
• Pulmonary edema (rales, hypoxia)
• Seizures
• Coma

Characteristic Acid-Base Patterns

The mixed acid-base disorder is pathognomonic for salicylate toxicity and provides diagnostic and prognostic information. [17]

Mixed Respiratory Alkalosis + High Anion Gap Metabolic Acidosis

Clinical Correlation:

• Normal pH does NOT mean mild toxicity (may be severe mixed disorder)
• Low PaCO2 with low HCO3- is classic pattern
• Anion gap acidosis develops as toxicity progresses
• Respiratory fatigue → rising PaCO2 → acidemia → clinical deterioration
• Intubation removes respiratory compensation → sudden severe acidemia

Interpretation Pearls:

1. Early: Isolated respiratory alkalosis (pH greater than 7.45, low PaCO2)

   • CNS stimulation predominates
   • Metabolic effects not yet manifest

2. Typical: Mixed disorder (pH ~7.4, low PaCO2, low HCO3-, elevated AG)

   • Simultaneous respiratory alkalosis and metabolic acidosis
   • Most characteristic pattern
   • Can have seemingly "normal" pH masking severe disturbance

3. Severe: Metabolic acidosis predominates (pH less than 7.35)

   • Respiratory compensation inadequate
   • Indicates severe toxicity
   • May indicate respiratory fatigue (ominous)
   • Immediate hemodialysis consideration

Calculate the Anion Gap:

• AG = Na - (Cl + HCO3)
• Normal = 8-12 mEq/L
• Salicylate toxicity typically produces AG 16-30 mEq/L
• Very high AG (greater than 30) suggests severe toxicity or co-ingestion

Chronic Toxicity Presentation

Chronic salicylate toxicity is particularly insidious and frequently misdiagnosed. It deserves special emphasis due to higher morbidity and mortality. [11]

Typical Patient Profile:

• Elderly patient (greater than 65 years)
• Chronic aspirin use for cardiac/rheumatologic conditions
• Intercurrent illness, dehydration, or AKI
• Nonspecific complaints over days to weeks

Common Presentations:

• "Altered mental status"
• confusion, delirium, falls
• "Sepsis"
• fever, tachypnea, hypotension, elevated lactate
• "Decompensated heart failure"
• dyspnea, pulmonary edema
• "Acute delirium or dementia"
• "Unexplained metabolic acidosis"

Key Differentiating Features:

• Hyperventilation (if recognized, is key clue)
• Mixed acid-base disorder
• History of chronic aspirin use (must ask specifically)
• Tinnitus (may be absent or patient may not report)
• Lower salicylate levels cause severe toxicity (50-60 mg/dL can be critical)

Why Chronic Toxicity is More Dangerous:

• Greater tissue distribution has occurred over time
• More CNS and organ penetration at lower serum levels
• Often delayed diagnosis (attributed to other conditions)
• Elderly have less physiologic reserve
• More likely to have renal impairment, dehydration
• Higher mortality (25% vs 1-2% for acute)

High Index of Suspicion Required:

• Consider salicylate level in ANY elderly patient with:
  • Unexplained altered mental status + hyperventilation
  • Unexplained high anion gap metabolic acidosis
  • Mixed acid-base disorder
  • Elevated lactate without clear source
  • Taking aspirin chronically who becomes unwell

---

Red Flags (Life-Threatening Findings)

Early recognition of these critical findings can be life-saving. Any of these warrants immediate escalation of care, ICU admission, and consideration of hemodialysis. [5,18]

Critical Clinical Findings

The Danger of Intubation

This cannot be overemphasized: Intubation of a patient with salicylate toxicity can be rapidly fatal if not performed correctly. This is one of the most important clinical pearls in toxicology. [13,19]

Why Intubation is Dangerous:

1. Loss of Respiratory Compensation

   • Patient spontaneously hyperventilating to maintain pH (e.g., RR 40, PaCO2 15)
   • Standard ventilator settings (RR 12-16, TV 6-8 mL/kg) drastically reduce minute ventilation
   • PaCO2 rises rapidly (e.g., 15 → 40 mmHg within minutes)

2. Acute Respiratory Acidosis

   • Rising PaCO2 → falling pH
   • Example: pH 7.40 → 7.10 within 10-20 minutes post-intubation

3. Massive CNS Salicylate Influx

   • Falling pH → increased unionized salicylate → rapid CNS penetration
   • Intracellular salicylate can double or triple
   • Direct CNS toxicity, cerebral edema

4. Cardiovascular Collapse

   • Acidemia worsens cardiac function
   • Vasopressor requirements increase
   • Cardiac arrest can occur within 30-60 minutes
   • Well-described phenomenon: "crashing after intubation"

If Intubation is Absolutely Unavoidable:

Pre-Intubation:

1. Push IV sodium bicarbonate - 100-150 mEq IV bolus over 10-15 minutes
2. Optimize pH - Target pH 7.45-7.55 before intubation if time permits
3. Prepare vasopressors - Have norepinephrine or epinephrine drawn up and ready
4. Call for hemodialysis - Arrange emergent dialysis (often needed post-intubation)
5. Optimize potassium - Ensure K+ 4.0 mEq/L
6. Consider delayed sequence intubation - Maximize pre-oxygenation with CPAP/BiPAP

Intubation Strategy:

• Use ketamine for induction (maintains respiratory drive longer, cardiovascular stable)
• Avoid deep sedation initially if possible (allows some spontaneous breathing)
• Be prepared for severe hypotension

Post-Intubation Ventilator Settings:

• High respiratory rate: 24-30 breaths/min (match or exceed pre-intubation RR)
• Large tidal volumes: 8-10 mL/kg (match minute ventilation)
• Target PaCO2: Match or go BELOW pre-intubation PaCO2
• Example: If pre-intubation PaCO2 was 15, target 10-15 mmHg
• Check ABG immediately post-intubation and adjust

Post-Intubation Management:

• Continue aggressive IV bicarbonate infusion
• Vasopressor support as needed
• Arrange emergent hemodialysis (intubation is a relative indication)
• Frequent ABG monitoring (every 30-60 min initially)

Better Strategy: AVOID intubation whenever possible:

• Use non-invasive ventilation (CPAP, BiPAP) for hypoxia if feasible
• Aggressive medical management (bicarbonate, hemodialysis)
• Hemodialysis can rapidly improve clinical status, avoiding need for intubation
• Many patients improve with dialysis and never require intubation

---

Differential Diagnosis

The presentation of salicylate toxicity, particularly chronic toxicity, can mimic many other conditions. Maintaining a broad differential while actively considering salicylate toxicity is essential. [20]

Causes of Anion Gap Metabolic Acidosis

MUDPILES Mnemonic (classic, though CAT MUDPILES is more comprehensive):

Key Distinguishing Feature of Salicylate Toxicity:

• Mixed respiratory alkalosis + metabolic acidosis is nearly pathognomonic
• Low PaCO2 + Low HCO3- + Elevated anion gap = think salicylate!

Conditions with Similar Clinical Presentations

Clinical Pearl - When to Check Salicylate Level:

• ANY unexplained high anion gap metabolic acidosis
• ANY mixed respiratory alkalosis + metabolic acidosis
• Elderly patient with unexplained altered mental status + hyperventilation
• Unexplained fever + tachypnea + elevated lactate
• Known aspirin use with intercurrent illness
• When you've ruled out the "common" things and patient isn't improving

---

Diagnostic Approach

Early and accurate diagnosis is essential for appropriate management. The diagnosis requires clinical suspicion, key laboratory tests, and serial monitoring. [10,21]

Initial Assessment

Key Historical Elements:

For Suspected Acute Overdose:

• Type of salicylate ingested (aspirin, oil of wintergreen, topical)
• Amount ingested (number of pills, concentration, mg/kg)
• Timing of ingestion (exact time if possible)
• Formulation: Immediate-release vs enteric-coated vs sustained-release
  • Enteric-coated can delay peak levels by 6-12 hours
  • Sustained-release can cause prolonged absorption
• Intentional vs unintentional
• Co-ingestants (especially acetaminophen, other analgesics)
• Symptoms developed and timeline
• Past medical history (renal function, cardiac disease)
• Chronic aspirin use background

For Suspected Chronic Toxicity:

• Medication list - specifically ask about aspirin, aspirin-containing products
• Dose and duration of salicylate use
• Recent illness (infection, dehydration, decreased PO intake)
• Renal history
• Timeline of symptom development (often vague, over days-weeks)
• Falls, confusion, "not acting right"

Critical Questions:

1. "Do you take aspirin? How much and how often?"
2. "Do you take any medications for pain or your heart?"
3. "Did you take anything to harm yourself?"
4. "When exactly did you take the pills?"
5. "What type of pills - regular aspirin or coated?"

Laboratory Studies

Comprehensive laboratory evaluation is essential for diagnosis, severity assessment, and monitoring. [21]

Additional Studies in Severe Cases:

• Creatine kinase (if rhabdomyolysis suspected - seizures, hyperthermia)
• Magnesium, phosphate (electrolyte disturbances)
• Calcium (ionized) - hypocalcemia possible
• Chest X-ray (pulmonary edema)
• CT head (if altered mental status with concern for other pathology)

Salicylate Level Interpretation

Serum salicylate levels are essential for diagnosis and guide management, but must be interpreted in clinical context. [10]

Therapeutic and Toxic Ranges:

Critical Interpretation Caveats:

1. Chronic Toxicity Has Lower Thresholds:

   • Levels 50-60 mg/dL can represent severe toxicity
   • Greater tissue distribution has occurred
   • Clinical status more important than absolute level
   • Hemodialysis may be indicated at levels greater than 60-70 mg/dL if symptomatic

2. Peak Levels May Be Delayed:

   • Immediate-release: Peak 1-2 hours
   • Enteric-coated: Peak 4-6 hours (sometimes up to 12-24 hours)
   • Sustained-release: Prolonged absorption, multiple peaks possible
   • Bezoar formation: Unpredictable, prolonged absorption

3. Serial Levels Are Essential:

   • Single level insufficient (cannot determine if rising or falling)
   • Repeat every 2-4 hours until:
     • Clear peak identified
     • Levels declining
     • Two consecutive declining levels documented
   • Rising levels indicate continued absorption (may need repeat charcoal, WBI, or hemodialysis)

4. Clinical Status Trumps Level:

   • Severely symptomatic patient with "moderate" level → treat as severe
   • Altered mental status, seizures, pulmonary edema → hemodialysis regardless of level
   • Done nomogram is NOT reliable for management decisions

5. Acid-Base Status Affects Toxicity:

   • Acidemic patients are more toxic at same level (more tissue distribution)
   • pH must be considered alongside salicylate level

The Done Nomogram (Historical Tool - NOT RECOMMENDED)

Background:

• Developed in 1960 to predict severity based on level and time post-ingestion
• Single level plotted on nomogram graph

Why It's No Longer Used: [22]

• Only applies to single, acute ingestions of immediate-release aspirin
• Does NOT account for:
  • Acid-base status (critical determinant of toxicity)
  • Chronic toxicity (completely unreliable)
  • Enteric-coated or sustained-release formulations
  • Clinical presentation
  • Co-morbidities
• Frequently leads to under-treatment
• Modern management focuses on clinical status, serial levels, and physiology

Current Approach:

• Manage based on clinical presentation + serial levels + acid-base status
• Done nomogram should NOT be used for clinical decision-making

Acid-Base Analysis

Careful acid-base analysis provides diagnostic and prognostic information and guides treatment.

Step-by-Step Approach:

1. Check pH:

   • less than 7.35 = acidemia
   • 7.35-7.45 = normal (but could be mixed disorder!)
   • greater than 7.45 = alkalemia

2. Identify Primary Disorder(s):

   • PaCO2 less than 35 = respiratory alkalosis
   • HCO3- less than 22 = metabolic acidosis

3. Calculate Anion Gap:

   • AG = Na - (Cl + HCO3)
   • Normal = 8-12
   • Elevated AG with low HCO3- = anion gap metabolic acidosis

4. Check for Mixed Disorder:

   • Salicylate = BOTH low PaCO2 AND low HCO3- simultaneously
   • Classic pattern: pH ~7.40, PaCO2 15-20, HCO3- 12-18, AG 18-28

5. Calculate Expected Compensation (to confirm mixed disorder):

   • For metabolic acidosis alone: Expected PaCO2 = (1.5 × HCO3-) + 8 ± 2
   • If actual PaCO2 is less than expected, concurrent respiratory alkalosis present
   • Salicylate almost always has PaCO2 much lower than expected

Example Case:

• pH 7.38, PaCO2 18, HCO3- 10, Na 140, Cl 102
• AG = 140 - (102 + 10) = 28 (elevated)
• Expected PaCO2 for HCO3- 10 = (1.5 × 10) + 8 = 23
• Actual PaCO2 (18) is much lower than expected (23) → concurrent respiratory alkalosis
• Interpretation: Mixed respiratory alkalosis + anion gap metabolic acidosis → salicylate toxicity

Imaging Studies

Abdominal X-ray (KUB):

• May show radiopaque pills in stomach/intestines
• Aspirin is variably radiopaque (less than iron)
• Useful if:
  • Massive ingestion suspected
  • Bezoar suspected
  • Uncertainty about ingestion timing
• Negative x-ray does NOT rule out toxicity
• Enteric-coated tablets more radiopaque

Chest X-ray:

• Indicated if respiratory symptoms
• Findings:
  • Normal (early)
  • Pulmonary edema (bilateral, non-cardiogenic)
  • ARDS pattern
• Helps differentiate cardiac vs non-cardiogenic pulmonary edema

CT Head:

• Only if concern for other pathology (trauma, ICH, stroke)
• Salicylate toxicity itself does not require head imaging
• Cerebral edema is a clinical diagnosis (and rare)

---

Treatment

Management of salicylate toxicity is multi-modal, requiring gastrointestinal decontamination, enhanced elimination through urinary alkalinization, meticulous supportive care, and hemodialysis in severe cases. Early aggressive treatment significantly improves outcomes. [5,6,23]

General Approach and Resuscitation

Initial Stabilization (ABC Approach):

1. Airway:

   • Assess airway patency and protect if needed
   • AVOID intubation unless absolutely necessary (see Red Flags section)
   • Consider non-invasive ventilation if hypoxic

2. Breathing:

   • Supplemental oxygen for hypoxia (target SpO2 greater than 94%)
   • Do NOT suppress hyperventilation - this is protective!
   • Monitor respiratory rate closely (fatigue = danger)

3. Circulation:

   • IV access (at least one large-bore IV)
   • Volume resuscitation if dehydrated or hypotensive
   • Initial bolus: 10-20 mL/kg normal saline
   • Monitor for fluid overload (risk of pulmonary edema)

4. Disability:

   • Rapid neurological assessment
   • Glucose check (and empiric D50W if altered mental status)
   • Dextrose-containing fluids mandatory

5. Exposure:

   • Core temperature (hyperthermia common)
   • Decontaminate skin if topical salicylate exposure

Early Interventions:

• Place on continuous cardiac monitoring
• Establish urine output monitoring (Foley catheter if severe)
• Contact poison control (1-800-222-1222 in US)
• Consult nephrology early if moderate-severe toxicity (hemodialysis preparation)

Gastrointestinal Decontamination

Activated Charcoal

First-line decontamination method for salicylate ingestion. [24]

Indications:

• Presentation within 2 hours of ingestion (standard)
• Extended window (up to 6-12 hours) for:
  • Enteric-coated formulations
  • Sustained-release formulations
  • Large ingestions (delayed gastric emptying)
  • Bezoar suspected

Dosing:

Single-dose activated charcoal (SDAC):
- Dose: 1 g/kg (typical adult: 50-100 g)
- Maximum: 50 g per dose
- Route: PO or nasogastric tube
- Formulation: Pre-mixed aqueous slurry preferred

Multi-dose activated charcoal (MDAC):
- Consider for large ingestions, enteric-coated, or rising levels
- Dose: 25-50 g every 4-6 hours
- Continue until salicylate levels clearly declining
- Enhances elimination (interrupts enterohepatic recirculation)

Contraindications:

• Unprotected airway with altered mental status (risk of aspiration)
• Bowel obstruction or perforation
• Recent GI surgery
• Inability to safely administer (combative patient)

Cautions:

• Vomiting is common (antiemetics may help: ondansetron 4-8 mg IV)
• Aspiration risk if mental status declines
• Intubate to protect airway if needed (with precautions) before charcoal

Efficacy:

• Most effective if given early (less than 1 hour)
• Still beneficial up to 2 hours
• Extended benefit with enteric-coated (delayed absorption)
• MDAC may enhance elimination even after absorption

Gastric Lavage:

• Generally NOT recommended (limited efficacy, complications)
• Consider only for:
  • Massive, life-threatening ingestion
  • Presentation within 1 hour
  • When performed by experienced provider
• Contraindications: unprotected airway, GI pathology

Whole Bowel Irrigation (WBI)

Indications:

• Enteric-coated or sustained-release formulations
• Rising salicylate levels despite activated charcoal
• Suspected bezoar formation
• Massive ingestion with radiopaque pills visible on x-ray

Protocol:

- Agent: Polyethylene glycol electrolyte solution (GoLYTELY)
- Dose: 1-2 L/hour via nasogastric tube (adults)
- Continue until rectal effluent is clear
- Duration: Typically 4-6 hours
- Monitor for abdominal distension, vomiting

Contraindications:

• Bowel obstruction, ileus, perforation
• Hemodynamic instability
• Unprotected airway with altered mental status
• GI bleeding

Endoscopy:

• Rarely indicated
• Consider only if massive bezoar suspected and refractory to medical management
• Can visualize and potentially remove pill concretions

Enhanced Elimination: Urinary Alkalinization

Urinary alkalinization is the cornerstone of medical management for moderate salicylate toxicity. It works by ion trapping, preventing renal reabsorption of salicylate and significantly enhancing elimination. [25,26]

Mechanism:

• Alkaline urine (pH greater than 7.5) ionizes salicylate in renal tubules
• Ionized salicylate cannot cross tubular membranes (trapped)
• Prevents reabsorption → enhanced urinary elimination
• Can increase renal clearance 10-20 fold
• Simultaneous systemic alkalinization also limits tissue distribution

Indications:

• Symptomatic salicylate toxicity (any level if symptomatic)
• Salicylate level greater than 30 mg/dL (even if asymptomatic)
• Clinical or laboratory evidence of toxicity

Contraindications (Relative):

• Pulmonary edema (fluid restrictions may conflict with alkalinization)
• Acute kidney injury (may be difficult to achieve; consider hemodialysis)
• Severe hypernatremia
• Severe hypokalemia that cannot be corrected (alkalinization will not work)

Standard Protocol:

Solution Preparation:
- Add 150 mEq (3 ampules of 50 mEq each) sodium bicarbonate to 1 liter D5W
- Alternatively: 150 mEq NaHCO3 in 850 mL D5W + 150 mL sterile water = 1L
- Final concentration: ~150 mEq/L bicarbonate + 5% dextrose

Infusion Rate:
- Initial: 150-250 mL/hour (approximately 2-3 times maintenance)
- Adjust based on urine pH and serum chemistry

Goals:
- Urine pH: 7.5-8.0 (check hourly with dipstick or pH meter)
- Serum pH: 7.45-7.55 (mild alkalemia is acceptable and therapeutic)
- Serum K+: Maintain 4.0 mEq/L (ESSENTIAL for success)
- Urine output: 2-3 mL/kg/hour

Duration:
- Continue until salicylate level less than 30 mg/dL and declining
- Typically 12-24 hours in acute overdose
- May require longer in chronic toxicity or massive ingestions

Critical Success Factors:

1. Potassium Repletion (MOST IMPORTANT):

   • Hypokalemia prevents effective alkalinization (H+/K+ exchange in kidney)
   • Must maintain serum K+ 4.0 mEq/L (preferably 4.0-4.5)
   • Aggressive potassium supplementation usually required:
     • Add 20-40 mEq KCl to each liter of bicarbonate solution
     • Additional IV potassium boluses as needed
     • Monitor K+ every 2-4 hours
   • Do NOT wait for urine pH to fail before giving K+; be proactive

2. Dextrose Administration:

   • Use D5W (or higher) as base solution
   • Addresses CNS glucose depletion
   • Prevents hypoglycemia
   • Mandatory in all salicylate toxicity patients

3. Volume Status:

   • Adequate hydration necessary for urine output
   • Aim for urine output 2-3 mL/kg/hour
   • Maintain euvolemia (avoid overload → pulmonary edema)

Monitoring During Alkalinization:

Troubleshooting Alkalinization:

Bicarbonate Boluses:

• May give bolus doses in addition to infusion
• Typical bolus: 50-100 mEq (1-2 ampules) IV over 10-15 minutes
• Indications: Severe acidemia (pH less than 7.2), inability to achieve urine alkalinization
• Monitor for overcorrection

Alternative Formulations:

• Some protocols use 3 ampules NaHCO3 in 1L sterile water (no dextrose)
  • "Risk: No dextrose (CNS glucose depletion)"
  • Not recommended as sole fluid
• If using, must give separate dextrose-containing fluids

Duration and Endpoint:

• Continue until salicylate level less than 30 mg/dL AND declining
• Clinical improvement (resolution of symptoms)
• Normalized acid-base status
• Typical duration: 12-24 hours (acute), may be longer (chronic)

Hemodialysis

Hemodialysis is the definitive treatment for severe salicylate toxicity. It directly removes salicylate, rapidly corrects acid-base disturbances, and reverses fluid/electrolyte abnormalities. Early nephrology consultation in moderate-severe cases is essential. [27,28]

Mechanisms of Benefit:

1. Direct salicylate removal (clearance 40-80 mL/min vs 15-30 mL/min with urine alkalinization)
2. Rapid correction of acidosis (removes acid, replenishes bicarbonate)
3. Correction of electrolyte abnormalities (K+, Na+, Ca2+)
4. Removal of lactate and ketoacids
5. Fluid removal (if overloaded)

Indications for Hemodialysis (EXTRIP Guidelines): [27]

Absolute Indications (Recommend Hemodialysis): ANY of the following:

• Salicylate level 90-100 mg/dL (acute) or greater than 60-70 mg/dL (chronic)
• CNS manifestations (altered mental status, seizures, coma)
• Refractory acidosis (pH less than 7.2 despite bicarbonate)
• Pulmonary edema or ARDS
• Acute kidney injury with inability to perform urinary alkalinization
• Cardiovascular compromise (hypotension, shock)

Relative Indications (Suggested):

• Salicylate level 70-90 mg/dL with symptoms
• Severe acid-base disturbance despite aggressive medical therapy
• Chronic toxicity with any significant symptoms (lower threshold!)
• Rising salicylate levels despite decontamination
• Failure of urinary alkalinization
• Significant co-morbidities (elderly, renal disease, heart failure)
• Need for intubation (dialysis may avoid intubation or make it safer)

Type of Dialysis:

• Intermittent hemodialysis (IHD) is preferred (most efficient salicylate removal)
• Continuous renal replacement therapy (CRRT) is less effective (slower clearance)
  • May use CRRT if IHD unavailable or hemodynamically unstable
  • Requires longer duration for equivalent clearance
• Peritoneal dialysis is NOT effective (inadequate clearance)

Dialysis Parameters:

• High blood flow rate (300-400 mL/min)
• High dialysate flow rate (500-800 mL/min)
• Large surface area dialyzer
• Duration: Typically 4-6 hours initially
• May need prolonged or repeat sessions if:
  • Rebound in salicylate level (redistribution from tissues)
  • Continued absorption (massive ingestion, bezoar)

Endpoints:

• Salicylate level less than 30-40 mg/dL (acute) or less than 20-30 mg/dL (chronic)
• Clinical improvement (improved mental status, no seizures)
• Resolution of acidosis (pH greater than 7.35)
• Stable acid-base status off dialysis

Post-Dialysis Management:

• Monitor for rebound in salicylate levels (redistribution from tissues)
• Check level 2-4 hours post-dialysis
• May need repeat dialysis if significant rebound
• Continue supportive care and monitoring

Special Considerations:

• Early consultation is key (don't wait for absolute indication)
• Dialysis can prevent deterioration and avoid need for intubation
• May be life-saving in severe cases
• Lower threshold in chronic toxicity, elderly, co-morbid conditions

Supportive Care

Meticulous supportive care is essential and can prevent complications.

Medications to AVOID:

• Aspirin or NSAIDs (obviously, but sometimes overlooked in chronic cases)
• Antipyretics (acetaminophen/ibuprofen ineffective for salicylate-induced hyperthermia)
• Aggressive diuresis without bicarbonate (worsens acidosis)
• Excessive sedation (may precipitate respiratory failure and need for intubation)

Airway Management (If Unavoidable)

See detailed section under Red Flags. If intubation is absolutely necessary:

Pre-Intubation Checklist:

• Push 100-150 mEq IV sodium bicarbonate
• Optimize serum potassium (4.0 mEq/L)
• Prepare vasopressors (drawn up and ready)
• Arrange emergent hemodialysis
• Check pre-intubation ABG (document PaCO2)
• Prepare high ventilator settings (RR 24-30, TV 8-10 mL/kg)

Intubation Technique:

• Use ketamine for induction (maintains respiratory drive, cardiovascular stability)
• Rapid sequence if needed
• Be prepared for immediate hypotension

Post-Intubation Management:

• Ventilator: High RR (24-30), large TV (8-10 mL/kg), target PaCO2 ≤ pre-intubation
• Immediate post-intubation ABG
• Continue bicarbonate infusion
• Vasopressor support as needed
• Emergent hemodialysis

---

Disposition and Monitoring

Appropriate triage, disposition, and monitoring are essential for safe patient care.

Admission Criteria

ICU Admission (any of the following):

• Salicylate level greater than 60 mg/dL (acute) or greater than 40 mg/dL (chronic)
• Any altered mental status
• Severe acid-base disturbance (pH less than 7.3 or greater than 7.55)
• Need for urinary alkalinization
• Need for hemodialysis
• Pulmonary edema or respiratory distress
• Hemodynamic instability
• Acute kidney injury
• Rising salicylate levels despite treatment
• Seizures
• Significant co-morbidities in elderly

Floor Admission (telemetry):

• Symptomatic with salicylate level 30-60 mg/dL
• Mild-moderate toxicity with stable vital signs
• Asymptomatic but level greater than 40 mg/dL
• Need for serial monitoring of levels
• Intentional ingestion (psychiatric hold)

Observation/Short Stay:

• Asymptomatic with level less than 30 mg/dL and declining
• Accidental ingestion, low dose
• Need to confirm declining levels before discharge

Discharge Criteria (all must be met):

• Asymptomatic
• Single, low-risk ingestion (less than 150 mg/kg immediate-release)
• Salicylate level less than 30 mg/dL and clearly declining
• Normal or near-normal acid-base status
• No co-ingestions
• Normal mental status
• Psychiatric clearance (if intentional ingestion)
• Reliable follow-up
• Poison control notification

Monitoring Requirements

ICU Monitoring (severe toxicity):

• Continuous cardiac telemetry
• Pulse oximetry
• Hourly vital signs
• Urine output (Foley catheter)
• Salicylate level every 2-4 hours until peak and then declining
• ABG/VBG every 2-4 hours
• Basic metabolic panel every 4-6 hours
• Urine pH hourly (if alkalinization)
• Neurological checks hourly
• Intake/output

Floor Monitoring (moderate toxicity):

• Continuous cardiac telemetry
• Vital signs every 2-4 hours
• Salicylate level every 4-6 hours
• VBG every 4-6 hours
• Basic metabolic panel every 6-8 hours
• Urine pH every 2-4 hours (if alkalinization)
• Neurological checks every 4 hours

Serial Salicylate Levels:

• Essential to document peak and declining trend
• Repeat every 2-4 hours initially
• Continue until:
  • Peak clearly identified
  • Two consecutive declining levels
  • Level less than 30 mg/dL
• Enteric-coated/sustained-release may require extended monitoring (24+ hours)

Consultation

Mandatory Consultations:

• Poison Control Center: All cases (1-800-222-1222 in US; 24/7 free consultation)
• Nephrology: Any moderate-severe toxicity (early for hemodialysis preparation)
• Psychiatry: All intentional ingestions (suicide risk assessment)
• ICU/Critical Care: Severe toxicity

Consider:

• Toxicology (if available)
• Gastroenterology (if massive GI bleeding or bezoar requiring endoscopy)

---

Special Populations

Chronic Salicylate Toxicity

Chronic toxicity has been discussed throughout but warrants emphasis due to high morbidity and mortality. [11]

Key Differences:

• Insidious onset over days to weeks
• Often misdiagnosed (sepsis, delirium, heart failure)
• Severe toxicity at lower serum levels (50-70 mg/dL)
• Greater tissue distribution
• Higher mortality (up to 25% vs 1-2% for acute)
• Done nomogram not applicable
• Lower threshold for hemodialysis

High-Risk Patients:

• Elderly (greater than 65 years)
• Chronic aspirin use for cardiac/rheumatologic conditions
• Intercurrent illness (infection, dehydration, AKI)
• Renal impairment
• Cognitive impairment
• Polypharmacy

Clinical Suspicion: Always consider chronic salicylate toxicity in elderly patients with:

• Unexplained altered mental status + hyperventilation
• Mixed acid-base disorder
• Elevated anion gap with elevated lactate
• Taking aspirin chronically

Management Principles:

• Treat as severe toxicity regardless of level
• Lower threshold for hemodialysis (consider if greater than 60-70 mg/dL with symptoms)
• No role for GI decontamination (chronic ingestion)
• Focus on urinary alkalinization and hemodialysis

Pediatric Considerations

Pediatric salicylate toxicity requires special attention due to different pharmacokinetics and higher susceptibility. [29]

Differences from Adults:

• Lower toxic dose threshold (greater than 150 mg/kg is concerning; greater than 200 mg/kg is severe)
• Metabolic acidosis may develop earlier and more severely
• CNS toxicity more prominent
• Higher risk of hypoglycemia
• Faster progression to severe toxicity

Oil of Wintergreen:

• Highly concentrated (1.4 g per mL)
• A single teaspoon (5 mL) = ~7 g = 21 adult aspirin tablets
• Frequently fatal in children
• Sweet taste → children may ingest large amounts
• Consider ALL oil of wintergreen ingestions as potentially life-threatening

Management:

• Same principles as adults (charcoal, alkalinization, hemodialysis)
• Adjusted dosing for weight
• Lower threshold for ICU admission and hemodialysis
• Careful fluid management (risk of cerebral edema)
• Frequent glucose monitoring and supplementation

Pregnancy

Salicylate toxicity in pregnancy presents unique challenges. [30]

Fetal Risks:

• Salicylates cross placenta freely
• Fetal acidemia may be worse than maternal (fetal pH lower)
• Increased risk of:
  • Fetal death
  • Premature closure of ductus arteriosus
  • Fetal hemorrhage
  • Placental abruption
  • Preterm labor

Maternal Risks:

• Pregnancy is already a respiratory alkalosis state (baseline PaCO2 ~30)
• Salicylate toxicity may be less obvious initially
• Risk of pulmonary edema may be higher

Management:

• Aggressive treatment (benefits outweigh risks)
• All standard treatments are acceptable:
  • Activated charcoal (safe in pregnancy)
  • Urinary alkalinization (safe)
  • Hemodialysis (safe and potentially life-saving for mother and fetus)
• Obstetric consultation
• Fetal monitoring (if viable gestational age)
• Consider delivery if fetal distress (after maternal stabilization)
• Lower threshold for hemodialysis (protects both mother and fetus)

Elderly

Elderly patients are at higher risk for both chronic toxicity and worse outcomes from acute toxicity.

Risk Factors:

• Reduced renal clearance (age-related GFR decline)
• Chronic aspirin use common (cardiac, arthritis)
• Polypharmacy (drug interactions, medication errors)
• Cognitive impairment (medication errors, delayed presentation)
• Decreased physiologic reserve
• More likely to have co-morbidities (CKD, HF, COPD)

Presentation:

• Often atypical (confusion, falls, "failure to thrive")
• May be misdiagnosed as sepsis, delirium, dementia
• Tinnitus may not be reported (baseline hearing loss)

Management Considerations:

• High index of suspicion
• Lower threshold for admission and aggressive treatment
• Lower threshold for hemodialysis
• Careful fluid management (risk of volume overload)
• Higher mortality - aggressive treatment justified

Renal Impairment

Chronic kidney disease significantly complicates salicylate toxicity. [14]

Issues:

• Reduced salicylate clearance (prolonged half-life)
• Accumulation with chronic use
• Difficult to achieve urinary alkalinization (may be impossible)
• Baseline acidosis (exacerbated by salicylate)

Management:

• Lower threshold for hemodialysis (may be only effective elimination method)
• Hemodialysis provides dual benefit (salicylate removal + renal replacement)
• Urinary alkalinization may be attempted but often ineffective
• Early nephrology consultation

---

Clinical Pearls and Key Concepts

Diagnostic Pearls

1. Mixed Acid-Base Disorder = Think Salicylate

   • Low PaCO2 + Low HCO3- + Elevated AG is nearly pathognomonic
   • "Normal" pH may mask severe mixed disorder

2. Check Salicylate Level Liberally

   • Any unexplained anion gap acidosis
   • Elderly with altered mental status + hyperventilation
   • Mixed acid-base disorder
   • Aspirin use + intercurrent illness

3. Chronic Toxicity is Worse

   • Lower levels cause severe symptoms (50-60 mg/dL can be critical)
   • Higher mortality
   • Often misdiagnosed
   • Lower threshold for hemodialysis

4. Tinnitus is Classic but Not Always Present

   • Nearly universal in acute toxicity
   • May be absent in chronic toxicity or hearing-impaired patients
   • Absence does NOT rule out toxicity

5. Serial Levels are Essential

   • Single level is insufficient
   • Must document peak and declining trend
   • Enteric-coated can have delayed peaks (6-24 hours)

Treatment Pearls

1. pH is Everything

   • Small pH changes have HUGE effects on tissue distribution
   • Alkalinization is therapeutic (limits CNS penetration, enhances elimination)
   • Acidosis is catastrophic (increases CNS penetration exponentially)

2. Intubation Can Kill

   • Avoid unless absolutely necessary
   • If needed: pre-treat with bicarbonate, hyperventilate, arrange emergent dialysis
   • Consider non-invasive ventilation first

3. Potassium is Essential for Alkalinization

   • Hypokalemia prevents urinary alkalinization (H+/K+ exchange)
   • Must maintain K+ 4.0 mEq/L
   • Be aggressive with potassium replacement

4. Always Give Dextrose

   • CNS glucose depleted despite normal serum glucose
   • Use D5W or D10W in all IV fluids
   • Critical principle, must never be omitted

5. Hemodialysis Saves Lives

   • Don't delay if indicated
   • Early consultation with nephrology
   • Definitive treatment for severe toxicity
   • Can prevent need for intubation

6. Serial Monitoring

   • Salicylate levels every 2-4 hours until declining
   • ABG every 2-4 hours
   • Electrolytes every 4-6 hours
   • Urine pH hourly during alkalinization

Disposition Pearls

1. ICU for All Moderate-Severe Toxicity

   • Level greater than 60 mg/dL (acute) or greater than 40 mg/dL (chronic)
   • Any altered mental status
   • Any significant acid-base disturbance
   • Need for alkalinization

2. Levels Must Be Declining Before Discharge

   • Two consecutive declining levels
   • Level less than 30 mg/dL
   • Asymptomatic
   • Normal acid-base status

3. Poison Control is Your Friend

   • Free 24/7 expert consultation
   • Call early and update as needed
   • 1-800-222-1222 (US)

4. Psychiatric Evaluation for All Intentional Ingestions

   • Suicide risk assessment
   • Disposition planning
   • Must be medically cleared first

5. Chronic Toxicity Has Worse Prognosis

   • Treat aggressively
   • Lower threshold for hemodialysis
   • Higher index of suspicion in elderly

---

Common Mistakes and How to Avoid Them

Diagnostic Errors

❌ Missing chronic toxicity in elderly patients

• Mistaking for sepsis, dementia, or delirium
• ✅ Check salicylate level in elderly with AMS + hyperventilation

❌ Relying on single salicylate level

• Cannot determine if rising or falling
• ✅ Serial levels every 2-4 hours until peak and declining

❌ Using Done nomogram for management

• Unreliable, doesn't account for acid-base status
• ✅ Manage based on clinical status + serial levels + physiology

❌ Assuming normal pH means mild toxicity

• May be severe mixed disorder with "balanced" pH
• ✅ Analyze full acid-base picture (pH, PaCO2, HCO3-, AG)

Treatment Errors

❌ Intubating without addressing acidosis

• Can cause cardiovascular collapse and death
• ✅ Pre-treat with bicarbonate, hyperventilate, arrange emergent dialysis

❌ Attempting alkalinization with hypokalemia

• Won't work due to H+/K+ exchange
• ✅ Aggressively replace potassium (maintain 4.0 mEq/L) FIRST

❌ Forgetting dextrose in IV fluids

• Worsens CNS glucose depletion
• ✅ Always use D5W or D10W in salicylate toxicity

❌ Delaying hemodialysis

• "Let's try medical management first" in severe toxicity
• ✅ Early nephrology consultation; don't hesitate if indicated

❌ Using diuretics for pulmonary edema

• Non-cardiogenic edema; diuretics ineffective
• ✅ Hemodialysis is definitive treatment

❌ Stopping monitoring too early

• Levels may continue to rise (enteric-coated, bezoar)
• ✅ Continue until clear peak and two declining levels

Disposition Errors

❌ Discharging based on single normal level

• May be early in absorption
• ✅ Document declining trend before discharge

❌ Undertreating chronic toxicity

• Lower levels cause severe toxicity
• ✅ Lower threshold for ICU and hemodialysis in chronic cases

❌ Missing co-ingestions

• Acetaminophen very common co-ingestion
• ✅ Always check acetaminophen level in intentional overdoses

---

Quality Metrics and Documentation

Performance Indicators

Documentation Requirements

History:

• Type and amount of salicylate ingested
• Time of ingestion
• Intentional vs unintentional
• Symptoms and timeline
• Chronic aspirin use
• Co-ingestions

Physical Examination:

• Vital signs (including respiratory rate)
• Mental status
• Respiratory examination
• Cardiovascular examination

Laboratory:

• Serial salicylate levels with times
• Serial ABG/VBG results
• Electrolytes, renal function
• Anion gap calculation
• Urine pH (if alkalinization)

Treatment:

• Decontamination methods and timing
• Urinary alkalinization protocol
• Fluids and electrolyte replacement
• Hemodialysis indication and timing
• Response to treatment

Consultations:

• Poison control (document recommendations)
• Nephrology (hemodialysis decision)
• Psychiatry (if intentional)

Disposition:

• Admission decision and rationale
• Level of care (ICU vs floor)
• Hemodialysis plan
• Follow-up plan

---

Patient Education

Understanding Salicylate Toxicity

What is it?

• Poisoning from too much aspirin or related medications
• Can occur from single large ingestion or build up over time
• Serious and potentially life-threatening
• Treatment is effective when started early

Why is it dangerous?

• Affects multiple organ systems
• Causes acid buildup in blood
• Can damage brain, kidneys, lungs
• Can be fatal without treatment

Prevention

For Patients on Chronic Aspirin:

• Take exactly as prescribed
• Don't increase dose without medical advice
• Avoid other aspirin-containing products (check labels)
• Stay hydrated, especially when ill
• Contact doctor if develop confusion, rapid breathing, ringing in ears

For Families:

• Store medications safely (locked, out of reach of children)
• Dispose of unused medications properly
• Be aware of oil of wintergreen toxicity (very dangerous in children)
• Child-resistant packaging

Warning Signs - Seek Immediate Care

• Ringing in the ears (tinnitus)
• Rapid or deep breathing
• Confusion or drowsiness
• Nausea and vomiting
• Fever and sweating
• Stomach pain
• Any intentional ingestion

After Overdose

For Intentional Ingestions:

• Mental health evaluation essential
• Follow-up with psychiatry
• Suicide prevention resources
• Secure medications at home
• Support system involvement

For Accidental/Chronic Toxicity:

• Medication reconciliation with doctor
• Review all aspirin-containing products
• Identify why toxicity occurred
• Adjust medications as needed
• Close medical follow-up

Discharge Instructions

Activity:

• Rest until fully recovered
• Avoid strenuous activity for 24-48 hours
• Return to normal activity as tolerated

Diet:

• Resume normal diet as tolerated
• Stay well hydrated

Medications:

• STOP aspirin (unless specifically instructed otherwise by cardiologist)
• Take prescribed medications only
• Avoid NSAIDs until cleared by doctor

Follow-Up:

• Primary care physician within 3-7 days
• Psychiatry (if intentional ingestion) - appointment before discharge
• Return to ED if any concerning symptoms

Return Precautions:

• Confusion or decreased alertness
• Difficulty breathing
• Chest pain
• Persistent vomiting
• Fever
• Any worsening symptoms

---

Evidence Base and Guidelines

Major Guidelines

EXTRIP (Extracorporeal Treatments in Poisoning) Workgroup [27]

• Comprehensive systematic review of hemodialysis in salicylate poisoning
• Published in Annals of Emergency Medicine, 2015
• Provides evidence-based hemodialysis criteria
• Recommends hemodialysis for: level 90-100 mg/dL (acute) or greater than 60-70 mg/dL (chronic), CNS symptoms, pH less than 7.2, pulmonary edema, AKI
• Strong recommendations based on moderate quality evidence

American Academy of Clinical Toxicology (AACT) [24,25]

• Position papers on:
  • Single-dose activated charcoal (2005)
  • Urinary alkalinization (2004)
  • Multi-dose activated charcoal (2023)
• Evidence-based recommendations for decontamination and enhanced elimination

Poison Control Centers/Toxicologists [2,3]

• Consensus expert opinion
• Widely adopted protocols for alkalinization and hemodialysis
• Emphasis on early aggressive treatment

Landmark Studies

While many publications on salicylate toxicity are case series and expert opinion due to ethical constraints on RCTs in poisoning, several key papers inform current practice:

Pathophysiology:

• Studies on mitochondrial uncoupling and oxidative phosphorylation disruption [4,5]
• pH-dependent tissue distribution studies [8,9]
• CNS glucose depletion mechanism [6,7]

Clinical Presentation:

• Chronic vs acute toxicity outcomes [11]
• Acid-base patterns and prognostic significance [17]
• Oil of wintergreen case series [9]

Treatment:

• Urinary alkalinization efficacy studies [25,26]
• Hemodialysis case series and systematic reviews [27,28]
• Intubation complications and outcomes [13,19]

Level of Evidence

Note: Randomized controlled trials in poisoning are limited due to ethical constraints. Much evidence is based on well-designed observational studies, case series, and pathophysiologic principles.

---

References

1. Dargan PI, Wallace CI, Jones AL. An evidenced based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. 2002;19(3):206-209. doi:10.1136/emj.19.3.206

2. O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. 2007;25(2):333-346. doi:10.1016/j.emc.2007.02.012

3. Pearlman BL, Gambhir R. Salicylate intoxication: a clinical review. Postgrad Med. 2009;121(4):162-168. doi:10.3810/pgm.2009.07.2041

4. Halstead BW, Hanel E. Salicylate poisoning: an analysis of 31 cases. N Engl J Med. 1957;256(4):155-159. doi:10.1056/NEJM195701242560401

5. Chyka PA, Erdman AR, Christianson G, et al. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(2):95-131. doi:10.1080/15563650600907140

6. McGuigan MA. A two-year review of salicylate deaths in Ontario. Arch Intern Med. 1987;147(3):510-512. doi:10.1001/archinte.1987.00370030118022

7. Thurston JH, Pollock PG, Warren SK, Jones EM. Reduced brain glucose with normal plasma glucose in salicylate poisoning. J Clin Invest. 1970;49(11):2139-2145. doi:10.1172/JCI106431

8. Hill JB. Salicylate intoxication. N Engl J Med. 1973;288(21):1110-1113. doi:10.1056/NEJM197305242882107

9. Davis JE. Are one or two dangerous? Methyl salicylate exposure in toddlers. J Emerg Med. 2007;32(1):63-69. doi:10.1016/j.jemermed.2006.05.022

10. Done AK. Salicylate intoxication. Significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics. 1960;26:800-807. PMID:13723147

11. Yip L, Dart RC, Gabow PA. Concepts and controversies in salicylate toxicity. Emerg Med Clin North Am. 1994;12(2):351-364. PMID:8187687

12. Gabow PA, Anderson RJ, Potts DE, Schrier RW. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med. 1978;138(10):1481-1484. doi:10.1001/archinte.1978.03630350021011

13. Stolbach A, Hoffman RS, Nelson LS. Mechanical ventilation was associated with acidemia in a case series of salicylate-poisoned patients. Acad Emerg Med. 2008;15(9):866-869. doi:10.1111/j.1553-2712.2008.00203.x

14. Ramsay AG, Minns RA. Salicylate poisoning in children: prevention of late deterioration in severely poisoned children. BMJ. 1989;298(6675):686-687. doi:10.1136/bmj.298.6675.686

15. Walters JS, Woodring JH, Stelling CB, Rosenbaum HD. Salicylate-induced pulmonary edema. Radiology. 1983;146(2):289-293. doi:10.1148/radiology.146.2.6849077

16. Vale JA, Proudfoot AT. How useful is measurement of plasma salicylate? Clin Toxicol (Phila). 2015;53(3):183-187. doi:10.3109/15563650.2015.1004579

17. Heffner JE, Sahn SA. Salicylate-induced pulmonary edema. Clinical features and prognosis. Ann Intern Med. 1981;95(4):405-409. doi:10.7326/0003-4819-95-4-405

18. Thisted B, Krantz T, Strøm J, Sørensen MB. Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. Acta Anaesthesiol Scand. 1987;31(4):312-316. doi:10.1111/j.1399-6576.1987.tb02571.x

19. Hedges JR, Morrissey WL, Leeper KV Jr. Ventilatory management in salicylate-induced pulmonary edema. Am J Emerg Med. 1989;7(6):672-675. doi:10.1016/0735-6757(89)90293-5

20. Anderson RJ, Potts DE, Gabow PA, Rumack BH, Schrier RW. Unrecognized adult salicylate intoxication. Ann Intern Med. 1976;85(6):745-748. doi:10.7326/0003-4819-85-6-745

21. Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med. 1981;141(3 Spec No):364-369. doi:10.1001/archinte.1981.00340030088020

22. Flomenbaum N. The Done nomogram is dead; long live the Done nomogram. Ann Emerg Med. 1994;23(3):593-594. doi:10.1016/s0196-0644(94)70086-2

23. Juurlink DN, Gosselin S, Kielstein JT, et al; EXTRIP Workgroup. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med. 2015;66(2):165-181. doi:10.1016/j.annemergmed.2015.03.031

24. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal. Clin Toxicol (Phila). 2005;43(2):61-87. PMID:15822758

25. Proudfoot AT, Krenzelok EP, Brent J, Vale JA. Does urine alkalinization increase salicylate elimination? If so, why? Toxicol Rev. 2003;22(3):129-136. doi:10.2165/00139709-200322030-00001

26. Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT. Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J (Clin Res Ed). 1982;285(6352):1383-1386. doi:10.1136/bmj.285.6352.1383

27. Juurlink DN, Gosselin S, Kielstein JT, et al. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med. 2015;66(2):165-181. doi:10.1016/j.annemergmed.2015.03.031

28. Fertel BS, Nelson LS, Goldfarb DS. Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. J Intensive Care Med. 2010;25(3):139-148. doi:10.1177/0885066609359592

29. Greenberg MI, Hendrickson RG, Hofman M. Deleterious effects of endotracheal intubation in salicylate poisoning. Ann Emerg Med. 2003;41(4):583-584. doi:10.1067/mem.2003.152

30. Rayburn WF, Aronow R, DeLancey B, Hogan MJ. Drug overdose during pregnancy: an overview from a metropolitan poison control center. Obstet Gynecol. 1984;64(5):611-614. PMID:6436644

---

Version History